Logo image of BALY

BALLY'S CORP (BALY) Stock Fundamental Analysis

NYSE:BALY - New York Stock Exchange, Inc. - US05875B3042 - Common Stock - Currency: USD

10.79  -0.18 (-1.64%)

Fundamental Rating

2

Overall BALY gets a fundamental rating of 2 out of 10. We evaluated BALY against 132 industry peers in the Hotels, Restaurants & Leisure industry. Both the profitability and financial health of BALY have multiple concerns. BALY is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

BALY had negative earnings in the past year.
In the past year BALY had a positive cash flow from operations.
In the past 5 years BALY always reported negative net income.
In the past 5 years BALY always reported a positive cash flow from operatings.
BALY Yearly Net Income VS EBIT VS OCF VS FCFBALY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

Looking at the Return On Assets, with a value of -5.48%, BALY is doing worse than 77.27% of the companies in the same industry.
BALY has a Return On Equity of -51.52%. This is in the lower half of the industry: BALY underperforms 64.39% of its industry peers.
BALY has a worse Return On Invested Capital (0.61%) than 75.76% of its industry peers.
Industry RankSector Rank
ROA -5.48%
ROE -51.52%
ROIC 0.61%
ROA(3y)-6.39%
ROA(5y)-4.24%
ROE(3y)-639.86%
ROE(5y)-385.68%
ROIC(3y)N/A
ROIC(5y)N/A
BALY Yearly ROA, ROE, ROICBALY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

1.3 Margins

BALY's Operating Margin of 2.15% is on the low side compared to the rest of the industry. BALY is outperformed by 73.48% of its industry peers.
BALY has a better Gross Margin (54.32%) than 64.39% of its industry peers.
BALY's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.15%
PM (TTM) N/A
GM 54.32%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.11%
GM growth 5Y-3.47%
BALY Yearly Profit, Operating, Gross MarginsBALY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

0

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BALY is destroying value.
The number of shares outstanding for BALY has been increased compared to 1 year ago.
BALY has more shares outstanding than it did 5 years ago.
BALY has a worse debt/assets ratio than last year.
BALY Yearly Shares OutstandingBALY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
BALY Yearly Total Debt VS Total AssetsBALY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 0.37, we must say that BALY is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of BALY (0.37) is worse than 81.06% of its industry peers.
BALY has a Debt/Equity ratio of 4.31. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 4.31, BALY is doing worse than 61.36% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 4.31
Debt/FCF N/A
Altman-Z 0.37
ROIC/WACC0.07
WACC8.3%
BALY Yearly LT Debt VS Equity VS FCFBALY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 0.75 indicates that BALY may have some problems paying its short term obligations.
BALY has a Current ratio (0.75) which is comparable to the rest of the industry.
BALY has a Quick Ratio of 0.75. This is a bad value and indicates that BALY is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.72, BALY perfoms like the industry average, outperforming 43.18% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.75
Quick Ratio 0.72
BALY Yearly Current Assets VS Current LiabilitesBALY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

4

3. Growth

3.1 Past

BALY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -13.94%.
Looking at the last year, BALY shows a decrease in Revenue. The Revenue has decreased by -1.93% in the last year.
BALY shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 36.16% yearly.
EPS 1Y (TTM)-13.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.7%
Revenue 1Y (TTM)-1.93%
Revenue growth 3Y22.83%
Revenue growth 5Y36.16%
Sales Q2Q%-4.74%

3.2 Future

BALY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.79% yearly.
BALY is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.25% yearly.
EPS Next Y85.86%
EPS Next 2Y37.91%
EPS Next 3Y23.79%
EPS Next 5YN/A
Revenue Next Year3.35%
Revenue Next 2Y4.9%
Revenue Next 3Y6.25%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BALY Yearly Revenue VS EstimatesBALY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
BALY Yearly EPS VS EstimatesBALY Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -2 -4 -6 -8 -10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BALY. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BALY. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BALY Price Earnings VS Forward Price EarningsBALY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

BALY's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. BALY is cheaper than 65.15% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.06
BALY Per share dataBALY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 -40

4.3 Compensation for Growth

A more expensive valuation may be justified as BALY's earnings are expected to grow with 23.79% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.91%
EPS Next 3Y23.79%

More info and screens

0

5. Dividend

5.1 Amount

BALY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BALLY'S CORP

NYSE:BALY (7/14/2025, 10:21:20 AM)

10.79

-0.18 (-1.64%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)05-12 2025-05-12/amc
Earnings (Next)07-29 2025-07-29/bmo
Inst Owners79.52%
Inst Owner Change0%
Ins Owners2.47%
Ins Owner Change-7.19%
Market Cap528.82M
Analysts50.91
Price Target14.74 (36.61%)
Short Float %0.27%
Short Ratio1.27
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-84.59%
Min EPS beat(2)-187.58%
Max EPS beat(2)18.41%
EPS beat(4)2
Avg EPS beat(4)-729.87%
Min EPS beat(4)-2765.33%
Max EPS beat(4)18.41%
EPS beat(8)2
Avg EPS beat(8)-615.91%
EPS beat(12)3
Avg EPS beat(12)-718.81%
EPS beat(16)4
Avg EPS beat(16)-567.8%
Revenue beat(2)0
Avg Revenue beat(2)-3.84%
Min Revenue beat(2)-4.31%
Max Revenue beat(2)-3.37%
Revenue beat(4)0
Avg Revenue beat(4)-4.56%
Min Revenue beat(4)-5.87%
Max Revenue beat(4)-3.37%
Revenue beat(8)0
Avg Revenue beat(8)-3.74%
Revenue beat(12)0
Avg Revenue beat(12)-3.75%
Revenue beat(16)1
Avg Revenue beat(16)-3.7%
PT rev (1m)-2.69%
PT rev (3m)-14.37%
EPS NQ rev (1m)0%
EPS NQ rev (3m)21.98%
EPS NY rev (1m)-0.11%
EPS NY rev (3m)26.98%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.17%
Revenue NY rev (1m)0.62%
Revenue NY rev (3m)-0.23%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.22
P/FCF N/A
P/OCF 6.32
P/B 0.66
P/tB N/A
EV/EBITDA 11.06
EPS(TTM)-8.58
EYN/A
EPS(NY)-1.15
Fwd EYN/A
FCF(TTM)-3.7
FCFYN/A
OCF(TTM)1.71
OCFY15.82%
SpS49.4
BVpS16.25
TBVpS-56.58
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.48%
ROE -51.52%
ROCE 0.77%
ROIC 0.61%
ROICexc 0.63%
ROICexgc 1.39%
OM 2.15%
PM (TTM) N/A
GM 54.32%
FCFM N/A
ROA(3y)-6.39%
ROA(5y)-4.24%
ROE(3y)-639.86%
ROE(5y)-385.68%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.11%
GM growth 5Y-3.47%
F-Score6
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 4.31
Debt/FCF N/A
Debt/EBITDA 10.04
Cap/Depr 91.53%
Cap/Sales 10.95%
Interest Coverage 0.18
Cash Conversion 24.49%
Profit Quality N/A
Current Ratio 0.75
Quick Ratio 0.72
Altman-Z 0.37
F-Score6
WACC8.3%
ROIC/WACC0.07
Cap/Depr(3y)125.58%
Cap/Depr(5y)105.92%
Cap/Sales(3y)17.68%
Cap/Sales(5y)13.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-13.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.7%
EPS Next Y85.86%
EPS Next 2Y37.91%
EPS Next 3Y23.79%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.93%
Revenue growth 3Y22.83%
Revenue growth 5Y36.16%
Sales Q2Q%-4.74%
Revenue Next Year3.35%
Revenue Next 2Y4.9%
Revenue Next 3Y6.25%
Revenue Next 5YN/A
EBIT growth 1Y147.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year413.88%
EBIT Next 3Y75.17%
EBIT Next 5YN/A
FCF growth 1Y28.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-64.09%
OCF growth 3Y11.25%
OCF growth 5Y3.91%